NYSE ARCA | ETF
The fund invests primarily in equity securities, principally common and preferred stocks of companies of any market capitalization.
Under normal market conditions, the fund invests at least 80% of its net assets, plus borrowings for investment purposes, in securities of companies principally engaged in the research, development, production, or distribution of products and services related to the health care industry ("health care companies").
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ASND | Ascendis Pharma AS | Healthcare | Biotechnology | 17.11% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 15.32% |
| LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 6.98% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 5.70% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 4.52% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 3.92% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 3.58% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 3.55% |
| RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 3.18% |
| 6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 3.11% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.87% |
| MASI | Masimo Corporation | Healthcare | Medical Devices | 2.65% |
| LNTH | Lantheus Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.61% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 2.41% |
| CVS | CVS Health Corp | Healthcare | Healthcare Plans | 2.32% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.25% |
| ICLR | ICON PLC | Healthcare | Diagnostics & Research | 2.13% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 2.11% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 1.93% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 1.83% |